NR1H4 and metabolic dysfunction-associated steatohepatitis: Most recently, we found that Gyps exerted a therapeutic effect during NASH (12, 13), in which the farnesoid X receptor (FXR) and its signaling pathway were up-regulated in a mouse model of high-fat diet (HFD)-induced NASH (12).